A R T I C L E I N F O A B S T R A C T
Pseudothrombocytopenia by ethylenediaminetetra acetic acid (EDTA) is an infrequent phenomenon of in vitro platelet agglutination due to the presence of antiplatelet autoantibodies. It has no clinical signifi cance, but misdiagnosis may lead to clinical or thera peutic decisionmaking. In this study, we report a case of an 8yearold boy with no history of platelet disor der presenting a low platelet count and a peripheral blood smear showing clumping of platelets by EDTA. The initial diagnosis hypothesis was of an idiopathic thrombocytopenic purpura, and an unnecessary bone marrow aspirate was made even though he did not have personal or family history of bleeding. A sec ond sample collected in sodium citrate confirmed the pseudothrombocytopenia by EDTA. In conclusion, the laboratory should enhance a strong relationship with clinicians trying to avoid misunderstandings as that reflected in this case report. It should be reminded that, in those cases where a pseudothrombocytope nia by EDTA is suspected, a blood smear is mandatory to confirm platelet clumps and blood must be tested anticoagulated with another anticoagu lant (i.e., sodium citrate or heparin).
INTRODUCTION
Several preanalytical factors could impact plate lets evaluation and jeopardize patient safety (1) . Therefore, laboratory professional should guar antee preanalytical procedures to avoid the fol lowing source of platelets variability:
• improperly fasting time (2,3)
• improperly tourniquet application time (4,5)
• unstandardized patient posture (6) • improper order of evacuated tubes (7, 8) • improper blood venous sampling (9) According to the World Health Organization (WHO), patient safety is the absence of pre ventable harm to a patient during the process of health care and reduction of risk of unneces sary harm associated with health care to an ac ceptable minimum (7) . The work in healthcare services should focus in the culture of patient safety, understanding that the problem is often a succession of several oversights or errors, from which we can learn and implement solutions to prevent them in the future.
Ethylenediaminetetraacetic acid (EDTA) is a cal cium chelator (10), widely used as an anticoagu lant for a complete blood count test because it generally does not distort blood cells. The term pseudothrombocytopenia by EDTA define a low platelet count in patients without any bleeding tendency, and platelet distribution curve that in dicates platelet aggregation (11) . Moreover, the patient should present a normal platelet count if a different anticoagulant is used (12) . The aim of this report is to show that a pseudothrombocyto penia by EDTA can jeopardize the patient safety.
CLINICAL-DIAGNOSTIC CASE
An 8yearold boy was referred to paediatric on cohaematology for presenting a twoyear evo lution thrombocytopenia with a platelet count below 20x10 3 /µL (Reference Interval: 130 400x10 3 /µL) with normal values of white blood cells (WBC) and haemoglobin (Hb) ( Table 1) . He did not have a significant past medical history, besides his familial hypercholesterolemia, and his clinical examination was unremarkable.
The initial diagnosis hypothesis was of an idi opathic thrombocytopenic purpura even though he did not have personal or family history of bleeding. A bone marrow aspirate was made, with no significant anomalies in the sample obtained. It was described as a normocellular marrow, showing trilinear haematopoiesis, with a preserved myeloid/erythroid ratio and a meg akaryocytic series without significative dysmor phias. At that moment the clinician realized that there was a commentary on the platelet count re marking the presence of plentiful platelet clumps in all the previous laboratory reports. The com plete blood count was repeated in the emergen cy laboratory. The platelet count was of 16x10 3 / µL together with a platelet clumps alarm in the automated cell counter (Advia 2120, Siemens Medical Solutions Diagnostics, Los Ángeles, CA, USA), without alterations in the other two hae matological series (Table 1) . Given this result, a peripheral blood smear was made, and multiple platelet clumps were observed (Figure 1 ). This was remarked in the laboratory report and a new sample was collected using an evacuated tube with 3.2% sodium citrate, as anticoagulant ad ditive (BD Vacutainer). The platelet count in this sample was normal (Table 1 ) and this result was discussed with the clinician. Physicians decide to perform a new blood collection with both anti coagulants 14 days after these results to confirm the pseudothrombocytopenia by EDTA (Table 1) .
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DISCUSSION
EDTAdependent pseudothrombocytopenia is an infrequent phenomenon of in vitro platelet agglutination due to the presence of antiplatelet autoantibodies (13, 14) ; its incidence has been reported to be between 0.10 and 0.29% (15) . As described in our case the agglutination in vitro results in a decrease in platelet count, typically below 100x10 3 /µL with the presence of a "plate let aggregation" alert flag from the analyser (16), the peripheral blood smear must be observed in order to confirm the presence of platelet clumps (17) . In addition, a new blood sample from the same patient using sodium citrate as anticoagu lant is the most suitable sample for the platelet count (18) . The laboratory professional has the responsibility of detecting these false thrombo cytopenias and notifying this information in the laboratory report (19) . Likewise, the clinician should consider this condition in order to avoid unnecessary diagnostic tests and therapeutic in terventions with the aim of preserving patient safety. Therefore, we would like to highlight the following learning points from this case report:
• The spurious low platelet count must be re ported together with a commentary on the presence of platelet clumps that underesti mate the real count.
• The clinical laboratory has an essential role over patient safety, but more efforts are re quired to prevent inappropriate clinical or therapeutic decisionmaking.
In conclusion, the laboratory should enhance a strong relationship with clinicians trying to avoid misunderstandings as that reflected in this case report. It should be reminded that, in those cas es where a pseudothrombocytopenia by EDTA is suspected, a blood smear is mandatory to con firm platelet clumps and blood must be tested anticoagulated with other anticoagulant (i.e., so dium citrate or heparin). 
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